Shuaiya Ma

机构：Henan Cancer Hospital · ORCID：0000-0001-6089-5246

发表论文 11 篇 · 总被引 289 次 · h-index 6

代表论文

• Palmitoylation of TIM-3 promotes immune exhaustion and restrains antitumor immunity (2024 · Science Immunology · 被引 85)
• Soluble Tim-3 serves as a tumor prognostic marker and therapeutic target for CD8+ T cell exhaustion and anti-PD-1 resistance (2024 · Cell Reports Medicine · 被引 58)
• Identification of a small-molecule Tim-3 inhibitor to potentiate T cell–mediated antitumor immunotherapy in preclinical mouse models (2023 · Science Translational Medicine · 被引 55)
• Ribosomal protein S26 serves as a checkpoint of T-cell survival and homeostasis in a p53-dependent manner (2021 · Cellular and Molecular Immunology · 被引 32)
• Urolithin A Hijacks ERK1/2‐ULK1 Cascade to Improve CD8 + T Cell Fitness for Antitumor Immunity (2024 · Advanced Science · 被引 30)
• Spatial distribution and functional analysis define the action pathway of Tim-3/Tim-3 ligands in tumor development (2021 · Molecular Therapy · 被引 16)